Semaglutide
GLP-1 receptor agonist reference material for incretin and metabolic research.
- Purity (HPLC)
- ≥99%
- Form
- Lyophilized
- Sizes
- 5 · 10 mg
Modified hGH 176–191 fragment studied in lipid-metabolism models.
For laboratory research use only. Not for human or veterinary use. Sold only to purchasers 21 or older who accept the research use policy.
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (residues 176–191) of human growth hormone with an added N-terminal tyrosine. The disulfide-bridged fragment was developed to retain the lipolytic region of hGH without the growth-promoting or insulin-related activity of the full hormone.
It has been studied in rodent adiposity models and in-vitro adipocyte assays. Supplied as a research reference material only.
The list above summarises where this compound appears in the scientific literature. It describes research activity, not properties or effects of any product sold here.
Calculate a reconstitution for this vial
Each lot is tested by an independent laboratory for purity (RP-HPLC) and identity (mass spectrometry). The certificate of analysis for your lot ships with the order; copies for any lot can be requested through the contact page with the lot number from the vial label. Read our guide on how to read a certificate of analysis.
GLP-1 receptor agonist reference material for incretin and metabolic research.
Dual GIP/GLP-1 receptor agonist for incretin-biology research.
Investigational triple GIP/GLP-1/glucagon receptor agonist.
This site sells synthetic peptides for in-vitro laboratory research. They are not for human or veterinary use and are not approved by the FDA for any purpose.